Clinical Trial Update: Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on nebulized heparin for COVID-19 and pneumonia; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Covid19
• Pneumonia

Drugs mentioned

• Nebulized Heparin (unfractionated heparin)

Snippet

Sponsor: Clinica San Camilo, Argentina | Conditions: Covid19, Pneumonia | Phase 4 | Status: UNKNOWN